A number of other research analysts have also recently weighed in on PRGO. Wells Fargo & Co reiterated a “hold” rating on shares of Perrigo in a research report on Tuesday, July 2nd. Cantor Fitzgerald lowered their target price on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating for the company in a report on Wednesday, June 12th. Finally, SunTrust Banks raised their target price on shares of Perrigo to $51.00 and gave the stock a “hold” rating in a report on Monday, May 20th. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $55.14.
Shares of Perrigo stock traded up $2.49 on Wednesday, reaching $55.26. The company had a trading volume of 1,809,770 shares, compared to its average volume of 1,323,670. The firm has a market cap of $6.92 billion, a price-to-earnings ratio of 12.15, a P/E/G ratio of 5.16 and a beta of 1.44. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.92 and a quick ratio of 1.39. The firm’s 50-day moving average price is $49.13 and its two-hundred day moving average price is $48.47. Perrigo has a 1 year low of $36.28 and a 1 year high of $75.72.
Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 8th. The company reported $0.86 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.81 by $0.05. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.13 billion. Perrigo had a return on equity of 9.57% and a net margin of 1.87%. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.22 EPS. As a group, analysts anticipate that Perrigo will post 3.94 EPS for the current year.
In other news, CFO Ronald Winowiecki sold 826 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $48.03, for a total transaction of $39,672.78. Following the completion of the sale, the chief financial officer now directly owns 6,952 shares of the company’s stock, valued at $333,904.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Theodore R. Samuels II bought 4,000 shares of the stock in a transaction dated Friday, August 9th. The shares were bought at an average cost of $46.97 per share, with a total value of $187,880.00. Following the completion of the purchase, the director now directly owns 8,236 shares of the company’s stock, valued at approximately $386,844.92. The disclosure for this purchase can be found here. Corporate insiders own 7.70% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. FTB Advisors Inc. boosted its holdings in shares of Perrigo by 0.3% in the second quarter. FTB Advisors Inc. now owns 65,283 shares of the company’s stock valued at $3,108,000 after purchasing an additional 197 shares during the period. State Treasurer State of Michigan raised its position in Perrigo by 0.6% during the 1st quarter. State Treasurer State of Michigan now owns 36,022 shares of the company’s stock valued at $1,735,000 after purchasing an additional 200 shares in the last quarter. Mason Street Advisors LLC raised its position in Perrigo by 1.2% during the 1st quarter. Mason Street Advisors LLC now owns 17,833 shares of the company’s stock valued at $859,000 after purchasing an additional 211 shares in the last quarter. World Asset Management Inc lifted its holdings in shares of Perrigo by 3.4% in the 2nd quarter. World Asset Management Inc now owns 8,014 shares of the company’s stock worth $382,000 after buying an additional 266 shares during the period. Finally, BNP Paribas Arbitrage SA lifted its holdings in shares of Perrigo by 0.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 46,822 shares of the company’s stock worth $2,230,000 after buying an additional 311 shares during the period. Institutional investors own 87.64% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Further Reading: Convertible Shares
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.